NMR characterization of intramolecular interaction of osteopontin, an intrinsically disordered protein with cryptic integrin-binding motifs

Biochemical and Biophysical Research Communications

Volumn 393, Issue 3, 2010, Pages 487-491

  Yamaguchi, Yoshiki ^a,b   Hanashima, Shinya ^b   Yagi, Hirokazu ^a   Takahashi, Yutaka ^a   Sasakawa, Hiroaki ^a,c   Kurimoto, Eiji ^a   Iguchi, Takeshi ^d   Kon, Shigeyuki ^e   Uede, Toshimitsu ^e   Kato, Koichi ^a,c,f  

^a NAGOYA CITY UNIVERSITY   (Japan)

^b Structural Glycobiology Team   (Japan)

^c INSTITUTE FOR MOLECULAR SCIENCE   (Japan)

^d Fujiya Co Ltd   (Japan)

^e HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^f OKAZAKI INSTITUTE FOR INTEGRATIVE BIOSCIENCE   (Japan)

Author keywords

Antibody; Integrin; Intrinsically disordered protein; NMR; Osteopontin

Indexed keywords

ARGININE; ASPARTIC ACID; EPITOPE; GLYCINE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY OPN1.2; OSTEOPONTIN; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; MOLECULAR INTERACTION; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PEPTIDE MAPPING; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN MOTIF;

AMINO ACID MOTIFS; ANIMALS; ANTIBODIES, MONOCLONAL; BINDING SITES; CIRCULAR DICHROISM; EPITOPE MAPPING; INTEGRINS; MICE; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; OSTEOPONTIN; PROTEIN CONFORMATION; RECOMBINANT PROTEINS;

EID: 77949318399     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.02.030     Document Type: Article

References (33)

1. Franzen A., and Heinegard D. Isolation and characterization of two sialoproteins present only in bone calcified matrix. Biochem. J. 232 (1985) 715-724
2. Sodek J., Ganss B., and McKee M.D. Osteopontin. Crit. Rev. Oral Biol. Med. 11 (2000) 279-303
3. Fisher L.W., Torchia D.A., Fohr B., Young M.F., and Fedarko N.S. Flexible structures of SIBLING proteins, bone sialoprotein, and osteopontin. Biochem. Biophys. Res. Commun. 280 (2001) 460-465
4. Denhardt D.T., Noda M., O'Regan A.W., Pavlin D., and Berman J.S. Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival. J. Clin. Invest. 107 (2001) 1055-1061
5. Denhardt D.T., and Guo X. Osteopontin: a protein with diverse functions. FASEB J. 7 (1993) 1475-1482
6. Sodek J., Batista Da Silva A.P., and Zohar R. Osteopontin and mucosal protection. J. Dent. Res. 85 (2006) 404-415
7. Yokosaki Y., Tanaka K., Higashikawa F., Yamashita K., and Eboshida A. Distinct structural requirements for binding of the integrins alphavbeta6, alphavbeta3, alphavbeta5, alpha5beta1 and alpha9beta1 to osteopontin. Matrix Biol. 24 (2005) 418-427
8. Bayless K.J., and Davis G.E. Identification of dual alpha 4beta1 integrin binding sites within a 38 amino acid domain in the N-terminal thrombin fragment of human osteopontin. J. Biol. Chem. 276 (2001) 13483-13489
9. Yokosaki Y., Matsuura N., Sasaki T., Murakami I., Schneider H., Higashiyama S., Saitoh Y., Yamakido M., Taooka Y., and Sheppard D. The integrin alpha(9)beta(1) binds to a novel recognition sequence (SVVYGLR) in the thrombin-cleaved amino-terminal fragment of osteopontin. J. Biol. Chem. 274 (1999) 36328-36334
10. Senger D.R., and Perruzzi C.A. Cell migration promoted by a potent GRGDS-containing thrombin-cleavage fragment of osteopontin. Biochim. Biophys. Acta 1314 (1996) 13-24
11. Senger D.R., Perruzzi C.A., Papadopoulos-Sergiou A., and Van de Water L. Adhesive properties of osteopontin: regulation by a naturally occurring thrombin-cleavage in close proximity to the GRGDS cell-binding domain. Mol. Biol. Cell 5 (1994) 565-574
12. Kaartinen M.T., Pirhonen A., Linnala-Kankkunen A., and Maenpaa P.H. Cross-linking of osteopontin by tissue transglutaminase increases its collagen binding properties. J. Biol. Chem. 274 (1999) 1729-1735
13. Schedlbauer A., Ozdowy P., Kontaxis G., Hartl M., Bister K., and Konrat R. Backbone assignment of osteopontin, a cytokine and cell attachment protein implicated in tumorigenesis. Biomol. NMR Assign. 2 (2008) 29-31
14. Gericke A., Qin C., Spevak L., Fujimoto Y., Butler W.T., Sorensen E.S., and Boskey A.L. Importance of phosphorylation for osteopontin regulation of biomineralization. Calcif. Tissue Int. 77 (2005) 45-54
15. Tompa P. The interplay between structure and function in intrinsically unstructured proteins. FEBS Lett. 579 (2005) 3346-3354
16. Dyson H.J., and Wright P.E. Intrinsically unstructured proteins and their functions. Nat. Rev. Mol. Cell Biol. 6 (2005) 197-208
17. Nishida N., Motojima F., Idota M., Fujikawa H., Yoshida M., Shimada I., and Kato K. Probing dynamics and conformational change of the GroEL-GroES complex by 13C NMR spectroscopy. J. Biochem. 140 (2006) 591-598
18. 13C-labelled proteins. J. Biomol. NMR 3 (1993) 113-120
19. Clore G.M., and Gronenborn A.M. Multidimensional heteronuclear nuclear magnetic resonance of proteins. Methods Enzymol. 239 (1994) 349-363
20. Kainosho M., and Tsuji T. Assignment of the three methionyl carbonyl carbon resonances in Streptomyces subtilisin inhibitor by a carbon-13 and nitrogen-15 double-labeling technique. A new strategy for structural studies of proteins in solution. Biochemistry 21 (1982) 6273-6279
21. Delaglio F., Grzesiek S., Vuister G.W., Zhu G., Pfeifer J., and Bax A. NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J. Biomol. NMR 6 (1995) 277-293
22. Hotta H., Kon S., Katagiri Y.U., Tosa N., Tsukamoto T., Chambers A.F., and Uede T. Detection of various epitopes of murine osteopontin by monoclonal antibodies. Biochem. Biophys. Res. Commun. 257 (1999) 6-11
23. Yamaguchi Y., Kim H., Kato K., Masuda K., Shimada I., and Arata Y. Proteolytic fragmentation with high specificity of mouse immunoglobulin G. Mapping of proteolytic cleavage sites in the hinge region. J. Immunol. Methods 181 (1995) 259-267
24. Yamamoto N., Sakai F., Kon S., Morimoto J., Kimura C., Yamazaki H., Okazaki I., Seki N., Fujii T., and Uede T. Essential role of the cryptic epitope SLAYGLR within osteopontin in a murine model of rheumatoid arthritis. J. Clin. Invest. 112 (2003) 181-188
25. Yamamoto N., Nakashima T., Torikai M., Naruse T., Morimoto J., Kon S., Sakai F., and Uede T. Successful treatment of collagen-induced arthritis in non-human primates by chimeric anti-osteopontin antibody. Int. Immunopharmacol. 7 (2007) 1460-1470
26. Sasakawa H., Sakata E., Yamaguchi Y., Masuda M., Mori T., Kurimoto E., Iguchi T., Hisanaga S., Iwatsubo T., Hasegawa M., and Kato K. Ultra-high field NMR studies of antibody binding and site-specific phosphorylation of alpha-synuclein. Biochem. Biophys. Res. Commun. 363 (2007) 795-799
27. Dedmon M.M., Lindorff-Larsen K., Christodoulou J., Vendruscolo M., and Dobson C.M. Mapping long-range interactions in alpha-synuclein using spin-label NMR and ensemble molecular dynamics simulations. J. Am. Chem. Soc. 127 (2005) 476-477
28. Bertoncini C.W., Jung Y.S., Fernandez C.O., Hoyer W., Griesinger C., Jovin T.M., and Zweckstetter M. Release of long-range tertiary interactions potentiates aggregation of natively unstructured alpha-synuclein. Proc. Natl. Acad. Sci. USA 102 (2005) 1430-1435
29. Bertoncini C.W., Fernandez C.O., Griesinger C., Jovin T.M., and Zweckstetter M. Familial mutants of alpha-synuclein with increased neurotoxicity have a destabilized conformation. J. Biol. Chem. 280 (2005) 30649-30652
30. Masuda K., Takahashi N., Tsukamoto Y., Honma H., and Kohri K. N-Glycan structures of an osteopontin from human bone. Biochem. Biophys. Res. Commun. 268 (2000) 814-817
31. Christensen B., Kazanecki C.C., Petersen T.E., Rittling S.R., Denhardt D.T., and Sorensen E.S. Cell type-specific post-translational modifications of mouse osteopontin are associated with different adhesive properties. J. Biol. Chem. 282 (2007) 19463-19472
32. Christensen B., Nielsen M.S., Haselmann K.F., Petersen T.E., and Sorensen E.S. Post-translationally modified residues of native human osteopontin are located in clusters: identification of 36 phosphorylation and five O-glycosylation sites and their biological implications. Biochem. J. 390 (2005) 285-292
33. Sorensen E.S., Hojrup P., and Petersen T.E. Posttranslational modifications of bovine osteopontin: identification of twenty-eight phosphorylation and three O-glycosylation sites. Protein Sci. 4 (1995) 2040-2049